Medicare only covers PRP injections for the treatment of chronic, nonhealing diabetic wounds. Coverage is limited to 20 weeks of treatment using FDA-approved equipment and technologies. Medicare does ...

Platelet-Rich Plasma (PRP) therapy has emerged as a promising orthobiologic intervention for knee osteoarthritis (OA), harnessing the patient’s own platelets and associated growth factors to modulate ...

Intra-articular injection therapies have become central to the symptomatic management of osteoarthritis by delivering bioactive agents directly into affected joints. Corticosteroids remain the most ...

EVERY DAY FOR nearly 15 years, Raynie Canoy woke up in head-to-toe pain that made it hard to function. Her neck, back, and knees ached, and her hips felt so tight that some days she could barely bend ...